Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Cancers|January 11, 2019
Enumerating Circulating Tumor Cells with a Self-Assembled Cell Array (SACA) Chip: A Feasibility Study in Patients with Colorectal CancerHsueh-Yao Chu, Long-Sheng Lu, Wanying Cho, et al.Circulation Research|April 26, 2003
Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbitsYen-Bin Liu, Chau-Chung Wu, Long-Sheng Lu, et al.Cancers|October 27, 2022
Molecularly Targeted Photothermal Ablation of Epidermal Growth Factor Receptor-Expressing Cancer Cells with a Polypyrrole-Iron Oxide-Afatinib NanocompositeLekshmi Rethi, Chinmaya Mutalik, Lekha Rethi, et al.Oncology Letters|February 6, 2018
Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancerYin-Ju Chen, Chia-Chun Kuo, Lai-Lei Ting, et al.Oncoimmunology|September 20, 2018
Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironmentChia-Jen Wu, Yi-Ting Tsai, I-Jung Lee, et al.Plos One|August 17, 2013
Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptorChih-Sheng Chu, Yu-Chen Wang, Long-Sheng Lu, et al.Cancers|January 8, 2020
Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma MultiformeHsun-Hua Lee, Che-Hsuan Lin, Hui-Yu Lin, et al.Cancers|September 19, 2020
Erratum: Lee, H.H., et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. <i>Cancers</i> 2020, <i>12</i>, 98Hsun-Hua Lee, Che-Hsuan Lin, Hui-Yu Lin, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 16, 2025
GKB202 suppresses endothelin-1/ERK signaling in pancreatic cancer cells: Potential implications for circulating tumor cell regulationYu-Fang Hu, Andy Y Chen, Jun-Way Chang, et al.Journal of Personalized Medicine|September 23, 2022
Retrospective Analysis for Dose Reduction to Organs at Risk with New Personalized Breast Holder (PERSBRA) in Left Breast IMRTChiu-Ping Chen, Tung-Ho Chen, Jeng-Fong Chiou, et al.Pageof 7